NDC 0944-2814

Aralast NP

Alpha-1-proteinase Inhibitor (human)

Aralast NP is a Kit in the Plasma Derivative category. It is labeled and distributed by Baxalta U.s. Inc.. The primary component is .

• Product ID: 0944-2814_25476011-16db-4de7-b1f8-191a193aae00
• NDC: 0944-2814
• Product Type: Plasma Derivative
• Proprietary Name: Aralast NP
• Generic Name: Alpha-1-proteinase Inhibitor (human)
• Dosage Form: Kit
• Marketing Start Date: 2002-12-23
• Marketing Category: BLA / BLA
• Application Number: BLA125039
• Labeler Name: Baxalta U.S. Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0944-2814-01

1 KIT in 1 CARTON (0944-2814-01) * 25 mL in 1 VIAL (0944-2803-03) * 25 mL in 1 VIAL, GLASS

• Marketing Start Date: 2002-12-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0944-2814-01 [00944281401]

ARALAST NP KIT

• Marketing Category: BLA
• Application Number: BLA125039
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2002-12-23

Drug Details

NDC Crossover Matching brand name "Aralast NP" or generic name "Alpha-1-proteinase Inhibitor (human)"

NDC	Brand Name	Generic Name
0944-2814	Aralast	Alpha-1-Proteinase Inhibitor (Human)
0944-2815	Aralast	Alpha-1-Proteinase Inhibitor (Human)
13533-700	PROLASTIN-C	ALPHA-1-PROTEINASE INHIBITOR (HUMAN)
13533-703	PROLASTIN-C	ALPHA-1-PROTEINASE INHIBITOR (HUMAN)
13533-706	PROLASTIN-C	ALPHA-1-PROTEINASE INHIBITOR (HUMAN)